MARVELD1 Antikörper (N-Term)

Produktnummer ABIN6991231

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch MARVELD1 in WB und ELISA. Er zeigt eine Reaktivität gegenüber Human, Maus und Ratte.

Kurzübersicht für MARVELD1 Antikörper (N-Term) (ABIN6991231)

Target: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MARVELD1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-MARVELD1 Antikörper

Bindungsspezifität: N-Term

Aufreinigung: MARVELD1 Antibody is affinity chromatography purified via peptide column.

Immunogen: MARVELD1 antibody was raised against a 16 amino acid synthetic peptide from near the amino terminus of human MARVELD1. The immunogen is located within the first 50 amino acids of MARVELD1.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: MARVELD1 antibody can be used for detection of MARVELD1 by Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: MARVELD1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: MARVELD1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Details zu MARVELD1

Target: MARVELD1 (MARVEL Domain Containing 1 (MARVELD1))

Andere Bezeichnung: MARVELD1

Hintergrund: MARVELD1 Antibody: MARVELD1, (MARVEL domain-containing 1), is one of the MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing proteins. It is a nuclear-localized protein that is widely expressed in normal human tissues. While it has been reported to be overexpressed in colon cancer, MARVELD1 protein levels are generally lower in several primary tumors including ovary, breast, kidney, bladder and liver. This lower level of MARVELD1 expression in tumors is thought to be due to a higher methylation status of the MARVELD1 promoter as treatment of MDA-MB-361 with 5-aza-2'-deoxycytidine restores MARVELD1 expression, suggesting that loss of MARVELD1 expression may contribute to tumorgenicity.

Gen-ID: 83742

UniProt: Q9BSK0